The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Isolation of transforming sequences of two human lung carcinomas: structural and functional analysis of the activated c-K-ras oncogenes.
Open accessAbstract
Human lung tumors PR310 and PR371 maintained in nude mice contain activated c-K-ras oncogenes detectable by the ability of their DNAs to induce the morphological transformation of NIH 3T3 mouse fibroblasts. Using phage libraries constructed with DNA from NIH 3T3 mouse fibroblast transformants, we have isolated human sequences that span greater than 40 kilobase pairs of the c-K-ras oncogene. Based on the conservation of these human sequences in mouse fibroblast transformants, we conclude that the transforming ability of the oncogene activated in these tumors resides within a 43- to 46-kilobase-pair DNA region. No clear differences were observed between the structures of the PR310 and PR371 cloned oncogene sequences. Nucleotide sequence analysis in concert with DNA transfection experiments suggests that the PR371 oncogene has been activated by a single base change in the first exon, which results in the substitution of cysteine for glycine in position 12 of the predicted amino acid sequence. The genetic alteration responsible for the transforming activity of the PR310 oncogene, however, does not reside in the first exon. These results indicate that the activation of the c-K-ras oncogene in human lung cancer can occur by different mutational events.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“KRAS G12C mutation was identified in the same year in a human lung tumour (PR371) that was propagated in nude mice [13].”
From Drugging KRAS: Current perspectives and state-of-art review (2022) · cites this paper as [13]
Citations
Cites
[57] Sequencing end-labeled DNA with base-specific chemical cleavages
Maxam, A. M., & Gilbert, W. (1980) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(80)65059-9 · Cited by 13,943
Screening λgt Recombinant Clones by Hybridization to Single Plaques in Situ
Benton, W. D., & Davis, R. W. (1977) · Science · doi:10.1126/science.322279 · Cited by 4,520
Mechanism of activation of a human oncogene
Tabin, C. J., Bradley, S. M., Bargmann, C. I., Weinberg, R. A., Papageorge, A. G., Scolnick, E. M., Dhar, R., Lowy, D. R., & Chang, E. H. (1982) · Nature · doi:10.1038/300143a0 · Cited by 1,393
Reddy, E. P., Reynolds, R. K., Santos, E., & Barbacid, M. (1982) · Nature · doi:10.1038/300149a0 · Cited by 1,391
Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue
Capon, D. J., Chen, E. Y., Levinson, A. D., Seeburg, P. H., & Goeddel, D. V. (1983) · Nature · doi:10.1038/302033a0 · Cited by 997
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 947
Der, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 793
Ellis, R. W., DeFeo, D., Shih, T. Y., Gonda, M. A., Young, H. A., Tsuchida, N., Lowy, D. R., & Scolnick, E. M. (1981) · Nature · doi:10.1038/292506a0 · Cited by 723
Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change
Taparowsky, E. J., Suard, Y. M. L., Fasano, O., Shimizu, K., Goldfarb, M. P., & Wigler, M. H. (1982) · Nature · doi:10.1038/300762a0 · Cited by 703
Santos, E., Tronick, S. R., Aaronson, S. A., Pulciani, S., & Barbacid, M. (1982) · Nature · doi:10.1038/298343a0 · Cited by 624
Cited by
Sorted by citations
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
Almoguera, C., Shibata, D. K., Forrester, K., Wj, M., Arnheim, N., & Perucho, M. (1988) · Cell · doi:10.1016/0092-8674(88)90571-5 · Cited by 2,122
Self-citationRas oncogenes: split personalities
Karnoub, A. E., & Weinberg, R. A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2438 · Cited by 1,467
Understanding and targeting resistance mechanisms in NSCLC
Rotow, J. K., & Bivona, T. G. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.84 · Cited by 997
MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy
Kasinski, A. L., & Slack, F. J. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3166 · Cited by 956
The ras gene family and human carcinogenesis
Bos, J. L. (1988) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(88)90004-8 · Cited by 776
Evolution of tumours and the impact of molecular oncology
Klein, G., & Klein, E. (1985) · Nature · doi:10.1038/315190a0 · Cited by 655
Biological properties of human c-Ha-ras1 genes mutated at codon 12
Seeburg, P. H., Colby, W. W., Capon, D. J., Goeddel, D. V., & Levinson, A. D. (1984) · Nature · doi:10.1038/312071a0 · Cited by 567
Mutational Activation of the K-rasOncogene
Rodenhuis, S., van de Wetering, M. L., Mooi, W. J., Evers, S. G., van Zandwijk, N., & Bos, J. L. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710083171504 · Cited by 537
Ross, J. S., Wang, K., Gay, L. M., Al-Rohil, R. N., Rand, J. V., Jones, D., Lee, H. J., Sheehan, C. E., Otto, G. A., Palmer, G. A., et al. (2014) · The Oncologist · doi:10.1634/theoncologist.2013-0352 · Cited by 453
Santos, E., Martin-Zanca, D., Reddy, E. P., Pierotti, M. A., Della Porta, G., & Barbacid, M. (1984) · Science · doi:10.1126/science.6695174 · Cited by 418
Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia
Bos, J. L., Toksoz, D., Marshall, C. J., Vries, M. V., Veeneman, G. H., van der Eb, A. J., BOOM, J. H. V., Janssen, J. W. G., & Steenvoorden, A. C. M. (1985) · Nature · doi:10.1038/315726a0 · Cited by 362
Oncogene Amplification in Tumor Cells
Alitalo, K. K., & Schwab, M. (1986) · Advances in cancer research · doi:10.1016/s0065-230x(08)60201-8 · Cited by 340
Winter, E., Yamamoto, F., Almoguera, C., & Perucho, M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.22.7575 · Cited by 310
Self-citationBRAF and KRAS Mutations in Hyperplastic Polyps and Serrated Adenomas of the Colorectum
Yang, S., Farraye, F. A., Mack, C., Posnik, O., & O’Brien, M. J. (2004) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000141404.56839.6a · Cited by 281
Peinado, M. A., Malkhosyan, S. R., Velázquez, A., & Perucho, M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10065 · Cited by 258
Self-citationRas Farnesyltransferase: A New Therapeutic Target
Leonard, D. M. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970226l · Cited by 242
Comparative analysis of mutations in the p53 and K‐ras genes in pancreatic cancer
Berrozpe, G., Schaeffer, J., Peinado, M. A., Real, F. X., & Perucho, M. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580207 · Cited by 236
Self-citationThor, A. D., Hand, P. H., Wunderlich, D. A., Caruso, A., Muraro, R., & Schlom, J. (1984) · Nature · doi:10.1038/311562a0 · Cited by 222
Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas.
Theillet, C. G., Lidereau, R., Escot, C., Hutzell, P., Brunet, M., Gest, J., Schlom, J., & Callahan, R. (1986) · PubMed · Cited by 213
Transformation of Human Bronchial Epithelial Cells Transfected by Harvey ras Oncogene
Yoakum, G. H., Lechner, J. F., Gabrielson, E. W., Korba, B. E., Malan-Shibley, L. B., Willey, J. C., Valerio, M. G., Shamsuddin, A. M., Trump, B. F., & Harris, C. C. (1985) · Science · doi:10.1126/science.3975607 · Cited by 191
Manne, V., Bekesi, E., & Kung, H. F. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.2.376 · Cited by 177
Reynolds, S. H., Stowers, S. J., Maronpot, R. R., Anderson, M. W., & Aaronson, S. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.1.33 · Cited by 176
Activation of a c-K- ras Oncogene by Somatic Mutation in Mouse Lymphomas Induced by Gamma Radiation
Guerrero, I., Villasanté, A., Corces, V. G., & Pellicer, À. (1984) · Science · doi:10.1126/science.6474169 · Cited by 175
Biochemical activities of the ParA partition protein of the P1 plasmid
Davis, M. A., Martin, K., & Austin, S. J. (1992) · Molecular Microbiology · doi:10.1111/j.1365-2958.1992.tb01552.x · Cited by 165
Drugging KRAS: Current perspectives and state-of-art review
Parikh, K., Banna, G., Liu, S. V., Friedlaender, A., Desai, A., Subbiah, V., & Addeo, A. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01375-4 · Cited by 164
“KRAS G12C mutation was identified in the same year in a human lung tumour (PR371) that was propagated in nude mice [13].”
BackgroundBos, J. L., Vries, M. V.-D., Jansen, A. M., Veeneman, G. H., BOOM, J. H. V., & van der Eb, A. J. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.23.9155 · Cited by 162
Genetics of neuroendocrine and carcinoid tumours.
Leotlela, P. D., Jauch, A. T., Holtgreve-Grez, H., & Thakker, R. V. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100437 · Cited by 162
Taya, Y., Hosogai, K., Hirohashi, S., Shimosato, Y., Tsuchiya, R., Tsuchida, N., Fushimi, M., Sekiya, T., & Nishimura, S. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb02236.x · Cited by 157
Human cancer and cellular oncogenes
Nishimura, S., & Sekiya, T. (1987) · Biochemical Journal · doi:10.1042/bj2430313 · Cited by 153
Sekiya, T., Fushimi, M., Hori, H., Hirohashi, S., Nishimura, S., & Sügimura, T. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.15.4771 · Cited by 127
Vousden, K. H., Bos, J. L., Marshall, C. J., & Phillips, D. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.5.1222 · Cited by 127
Ras p21 proteins with high or low GTPase activity can efficiently transform NIH3T3 cells
Lacal, J. C., Srivastava, S. K., Anderson, P. S., & Aaronson, S. A. (1986) · Cell · doi:10.1016/0092-8674(86)90270-9 · Cited by 111
Tremblay, P. J., Pothier, F., Hoang, T., Tremblay, G. A., Brownstein, S., Liszauer, A., & Jolicoeur, P. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.2.854 · Cited by 95
Huang, M., Chida, K., Kamata, N., Nose, K., Kato, M., Homma, Y., Takenawa, T., & Kuroki, T. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81311-x · Cited by 92
Lacal, J. C., Santos, E., Notario, V., Barbacid, M., Yamazaki, S., Kung, H. F., Seamans, C., McAndrew, S. J., & Crowl, R. M. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.17.5305 · Cited by 88
Huang, C., Tong, J., & Schmidt, J. (1992) · Neuron · doi:10.1016/0896-6273(92)90030-h · Cited by 87
Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene
Valenzuela, D., & Groffen, J. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.2.843 · Cited by 86
The pediatric cancer quality of life inventory-32 (PCQL-32)
Varni, J. W., Katz, E. R., Seid, M., Quiggins, D. J. L., & Friedman-Bender, A. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980315)82:6 · Cited by 217
CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours
Costa-Cabral, S., Brough, R., Konde, A., Aarts, M., Campbell, J., Marinari, E., Riffell, J. L., Bardelli, A., Torrance, C. J., Lord, C. J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149099 · Cited by 77
Translating Genomics for Precision Cancer Medicine
Roychowdhury, S., & Chinnaiyan, A. M. (2014) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090413-025552 · Cited by 75
Molecular Pathways: MicroRNAs as Cancer Therapeutics
Melo, S. A., & Kalluri, R. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2010 · Cited by 73
Morales, C., García, M. J., Ribas, M., Miró, R., Muñoz, M., Caldas, C., & Peinado, M. A. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0759 · Cited by 73
Fukui, M., Yamamoto, T., Kawai, S., Maruo, K., & Toyoshima, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.17.5954 · Cited by 68
Manne, V., Yamazaki, S., & Kung, H. F. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.6953 · Cited by 66
Berrozpe, G., Timokhina, I., Yukl, S. A., Tajima, Y., Ono, M., Zelenetz, A. D., & Besmer, P. (1999) · Blood · doi:10.1182/blood.v94.8.2658.420k23_2658_2666 · Cited by 62
Pfeifer, A. M. A., Mark, G. E., Malan-Shibley, L. B., Graziano, S. L., Amstad, P., & Harris, C. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.10075 · Cited by 60
Muto, S., Yokoi, T., Gondo, Y., Katsuki, M., Shioyama, Y., Fujita, K.-I., & Kamataki, T. (1999) · Carcinogenesis · doi:10.1093/carcin/20.3.421 · Cited by 56
Structure of the c-Ki-ras Gene in a Rat Fibrosarcoma Induced by 1,8-Dinitropyrene
Tahira, T., Hayashi, K., Ochiai, M., Tsuchida, N., Nagao, M., & Sügimura, T. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.4.1349 · Cited by 52
Utilizing protein structure to identify non-random somatic mutations
Ryslik, G. A., Cheng, Y., Cheung, K.-H., Modis, Y., & Zhao, H. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-190 · Cited by 51
Lacal, J. C., & Aaronson, S. A. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.12.4214 · Cited by 51
Gambke, C., Hall, A., & Moroni, C. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.3.879 · Cited by 47
Chernov, A. V., Reyes, L., Xu, Z., Gonzalez, B., Golovko, G., Peterson, S. N., Perucho, M., Fofanov, Y., & Strongin, A. Y. (2015) · Epigenetics · doi:10.1080/15592294.2015.1020000 · Cited by 46
Self-citationTransforming Genes and Target Cells of Murine Spleen Focus-Forming Viruses
Ostertag, W., Stocking, C., Johnson, G. R., Kluge, N., Kollek, R., Franz, T., & Hess, N. K. (1987) · Advances in cancer research · doi:10.1016/s0065-230x(08)60693-4 · Cited by 45
Activation of a human c-K-rasoncogeoe
Yamamoto, F., & Perucho, M. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.23.8873 · Cited by 42
Self-citationOrgan specific expression of ras oncoproteins during growth and development of the rat
Tanaka, T., Ida, N., Shimoda, H., Waki, C., Slamon, D. J., & Cline, M. (1986) · Molecular and Cellular Biochemistry · doi:10.1007/bf00233807 · Cited by 38
Involvement of the RAFI locus, at band 3p25, in the 3p deletion of small‐cell lung cancer
Graziano, S. L., Pfeifer, A. M. A., Testa, J. R., Mark, G. E., Johnson, B. E., Hallinan, E. J., Pettengill, O. S., Sorenson, G. D., Tatum, A. H., Brauch, H. B., et al. (1991) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870030407 · Cited by 37
Winter, E., & Perucho, M. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.7.2562 · Cited by 37
Self-citationTherapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models
Curatolo, A. D., Conciatori, F., Incani, U. C., Bazzichetto, C., Falcone, I., Corbo, V., D’Agosto, S. L., Eramo, A., Sette, G., Sperduti, I., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0820-5 · Cited by 36
Molecular staging of colorectal cancer
Thebo, J. S., Senagore, A. J., Reinhold, D. S., & Stapleton, S. R. (2000) · Diseases of the Colon & Rectum · doi:10.1007/bf02236973 · Cited by 34
Ye, X., Chan, K. C., Waters, A. M., Bess, M., Harned, A., Wei, B., Lončarek, J., Luke, B. T., Orsburn, B. C., Hollinger, B. D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13566 · Cited by 33
Amplification and enhanced expression of the c-Ki-ras2 protooncogene in human embryonal carcinomas.
Wang, L.-C., Vass, W. C., Gao, C., & Chang, K. S. S. (1987) · PubMed · Cited by 33
Kumar, S. U., Bithia, R., Kumar, D. T., Doss, C. G. P., & Zayed, H. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1830177 · Cited by 32
Masramon, L., Arribas, R., Tórtola, S., Perucho, M., & Peinado, M. A. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.390 · Cited by 32
Self-citationEnrique, P. (1985) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(85)90201-8 · Cited by 31
George, D. L., Glick, B. R., Trusko, S. P., & Freeman, N. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1651 · Cited by 30
O’Hara, B., Oskarsson, M. K., Tainsky, M. A., & Blair, D. G. (1986) · PubMed · Cited by 28
Oncogenes and Tumor-Suppressor Genes
Lehman, T. A., Reddel, R. R., Peiifer, A. M., Spillare, E. A., Kaighn, M. E., Weston, A., Gerwin, B. I., & Harris, C. C. (1991) · Environmental Health Perspectives · doi:10.1289/ehp.9193133 · Cited by 27
Head perturbations during walking while viewing a head-fixed target.
Das, V. E., Zivotofsky, A. Z., DiScenna, A. O., & Leigh, R. J. (1995) · PubMed · Cited by 27
Ki‐ras activation and expression in transformed mouse lung cell lines
Pan, Y. H. L., Nuzum, E. O., Hanson, L. A., & Beer, D. G. (1990) · Molecular Carcinogenesis · doi:10.1002/mc.2940030508 · Cited by 27
Chromatin structure of the promoter region of the human c-K-ras gene
Jordano, J., & Perucho, M. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.18.7361 · Cited by 27
Self-citationAnalysis of K-ras, N-ras, H-ras, and p53 in Lung Neuroendocrine Neoplasms
Couce, M., Bautista, D., Costa, J. C., & Carter, D. (1999) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199906000-00003 · Cited by 22
Growth and differentiation of normal and transformed human bronchial epithelial cells
Masui, T., Lechner, J. F., Yoakum, G. H., Willey, J. C., & Harris, C. C. (1986) · Journal of Cellular Physiology · doi:10.1002/jcp.1041290414 · Cited by 22
Multiomic characterization of oncogenic signaling mediated by wild-type and mutant RIT1
Lo, A., Holmes, K., Kamlapurkar, S., Mundt, F., Moorthi, S., Fung, I., Fereshetian, S., Watson, J., Carr, S. A., Mertins, P., et al. (2021) · Science Signaling · doi:10.1126/scisignal.abc4520 · Cited by 21
Tago, K., Funakoshi‐Tago, M., Ohta, S., Kawata, H., Saitoh, H., Horie, H., Aoki‐Ohmura, C., Yamauchi, J., Tanaka, A., Matsugi, J., et al. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12580 · Cited by 22
Ras2 and Ras1 Protein Phosphorylation in Saccharomyces cerevisiae
Whistler, J. L., & Rine, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18790 · Cited by 20
Wagner, S. N., Müller, R., Boehm, J., Pütz, B., Wünsch, P. H., & Höfler, H. (1993) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02899279 · Cited by 19
Mutational analysis of K-ras and Ras protein expression in larynx squamous cell carcinoma.
Ruı́z-Godoy, R. L. M., García-Cuellar, C. M., Ne, H. G., Bl, S., Pérez‐Cárdenas, E., Sánchez-Pérez, Y., Suárez‐Roa, M. D. L., & Meneses, A. (2006) · PubMed · Cited by 18
Cell type-specific expressions of c-ras gene products in the normal rat
Tanaka, T., Ida, N., Waki, C., Shimoda, H., Slamon, D. J., & Cline, M. J. (1987) · Molecular and Cellular Biochemistry · doi:10.1007/bf00231605 · Cited by 17
Neurospora crassa cDNA clones coding for a new member of the ras protein family
Altschuler, D. L., Muro, A. F., Schijman, A. G., Bravo-Almonacid, F. F., & Torres, H. N. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81061-r · Cited by 17
Mutational Spectrum of Fanconi Anemia Associated Myeloid Neoplasms
Chao, M. M., Thomay, K., Goehring, G., Włodarski, M. W., Pastor, V. M. L., Schlegelberger, B., Schindler, D., Kratz, C. P., & Niemeyer, C. M. (2017) · Klinische Pädiatrie · doi:10.1055/s-0043-117046 · Cited by 17
Yamamoto, F., & Yamamoto, M. (2008) · Gene Expression · doi:10.3727/105221608786883816 · Cited by 16
Self-citationMohn, G. R., & van Zeeland, A. A. (1985) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(85)90113-7 · Cited by 16
Perucho, M., & Estéban, M. (1985) · Journal of Virology · doi:10.1128/jvi.54.1.229-232.1985 · Cited by 13
Self-citationJazieh, K., Molina, J. R., Allred, J. B., Yin, J., Reid, J. M., Goetz, M. P., Lim, V.-S., Kaufmann, S. H., & Adjei, A. A. (2018) · Investigational New Drugs · doi:10.1007/s10637-018-0662-1 · Cited by 11
Suppression of Pancreatic and Colon Cancer Cells by Antisense K-ras RNA Expression Vectors
Aoki, K., Ohnami, S., & Yoshida, T. (2004) · Humana Press eBooks · doi:10.1385/1-59259-854-4:193 · Cited by 11
Qi, C., Chen, Y., Zhou, Y., Huang, X., Li, G., Zeng, J., Ruan, Z., Xie, X., & Zhang, J. (2018) · Oncology Reports · doi:10.3892/or.2018.6303 · Cited by 10
Colon carcinoma K-ras 2 oncogene of a familial polyposis coli patient.
Yuasa, Y., Oto, M., Sato, C., Miyaki, M., Iwama∥, T., Tonomura, A., & Namba, M. (1986) · PubMed · Cited by 9
Malignant Giant Cell Tumor of Bone With a KRAS G12V Mutation
Donigian, S., Whiteway, S. L., Hipp, S. J., Lybeck, D., & Clark, R. O. (2021) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002112 · Cited by 8
Kagimoto, M., Miyoshi, J., Tashiro, K., Naito, Y., Sakaki, Y., Sueishi, K., Tanaka, K., & Imamura, T. (1985) · International Journal of Cancer · doi:10.1002/ijc.2910350618 · Cited by 8
Li, N., Liu, C., Zhang, W., & Rao, G. (2023) · Current Medicinal Chemistry · doi:10.2174/0109298673258913231019113814 · Cited by 7
Boehm, T. L. J. (1985) · Progress in clinical biochemistry and medicine · doi:10.1007/978-3-642-70570-0_1 · Cited by 7
A Human Ki-ras Oncogene Encodes Two Transforming p21 Proteins
McCoy, M. S., & Weinberg, R. A. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.4.1326 · Cited by 7
Adamopoulos, P. G., Tsiakanikas, P., Boti, M. A., & Scorilas, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413298 · Cited by 6
Huang, M., Kamata, N., Nose, K., & Kuroki, T. (1988) · Molecular Carcinogenesis · doi:10.1002/mc.2940010206 · Cited by 5
Nucleic Acid Sequence Database VI: Retroviral Oncogenes and Cellular Proto-Oncogenes
CHEN, H. R., & Barker, W. C. (1985) · DNA · doi:10.1089/dna.1985.4.171 · Cited by 5
DNA analysis in human disease.
Wright, A. F. (1986) · Journal of Clinical Pathology · doi:10.1136/jcp.39.12.1281 · Cited by 5
Lobach, D. F., Bolognesi, D. P., & Kaufman, R. E. (1985) · Cancer Investigation · doi:10.3109/07357908509017497 · Cited by 4
Detection of oncogene‐related proteins with site‐directed monoclonal antibody probes
Niman, H. L. (1987) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.1860010105 · Cited by 4
Critical amino acids of p21 protein are located within β-turns: Further evaluation
Murakami, M. (1987) · Journal of Theoretical Biology · doi:10.1016/s0022-5193(87)80076-0 · Cited by 4
Metadata
- Authors
- Nakano, H., Yamamoto, F., Neville, C., Evans, D., Mizuno, T., & Perucho, M.
- Affiliations
- Stony Brook University (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1984-01
- Volume
- 81
- Issue
- 1
- Pages
- 71-75
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC344612
- OpenAlex
- W1986093376
- Cited by
- 133
- References
- 30
- Citations by year
- 2023: 3 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 1 · 2018: 4 · 2017: 3 · 2016: 2 · 2015: 1 · 2014: 5 · 2013: 3 · 2012: 1
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
- Keywords
- oncogene activation, lung cancer, point mutations, cysteine substitution, oncogene structure, nude mouse xenograft, mutational mechanisms
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cell Line, Cell Transformation, Neoplastic, Chimera, Cloning, Molecular, DNA Restriction Enzymes, DNA, Neoplasm, Humans, Lung Neoplasms, Mice, Nude, Neoplasm Transplantation, Nucleic Acid Hybridization, Oncogenes, Transplantation, Heterologous, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review